Bispecific Antibodies Market
According to Intent Market Research, the Bispecific Antibodies Market is expected to grow from USD 3.3 billion in 2023 at a CAGR of 15.6% to touch USD 9.0 billion by 2030. The Bispecific Antibodies Market is dominated by key players such as, AstraZeneca, Amgen, Chugai Pharmaceutical, Novartis, and Genentech